Marketdash
Back to Stock Market News

These Stocks Climbed While the Market Took a Breather Tuesday

MarketDash Editorial Team
4 hours ago
While the Dow Jones slipped slightly on Tuesday, a handful of stocks defied the downward trend. CapsoVision led the charge with an 8.4% gain after submitting an FDA application for its AI-assisted capsule endoscopy module, while AXT and Ultragenyx both surged over 13% on company-specific catalysts.

The broader market wasn't exactly throwing a party on Tuesday, with the Dow Jones index dipping more than 0.1%. But while the major indices were taking a collective nap, some individual stocks were wide awake and climbing.

CapsoVision, Inc. (CV) led the day's winners with a sharp rally during Tuesday's trading session. The medical device company submitted its 510(k) application to the FDA for its proprietary AI-assisted module for CapsoCam Plus, a development that investors clearly liked. Shares jumped 8.4% to $12.55.

The Day's Other Big Movers

Several other stocks posted impressive gains despite the lackluster market backdrop:

AXT, Inc. (AXTI) soared 13.5% to $16.56 after announcing it priced an $87 million public offering of 7,098,492 shares at $12.25 per share. That pricing came in well below where the stock was trading, which might seem counterintuitive to the rally, but the market apparently focused on the capital raise itself.

Ultragenyx Pharmaceutical Inc. (RARE) bounced back with a 13.6% gain to $22.40. This looks like a classic dead cat bounce after the stock plunged 42% on Monday when the company and partner Mereo BioPharma Group plc (MREO) disclosed disappointing late-stage data for their rare bone disease program. Sometimes stocks fall so hard they just have to recover a bit.

Greenwich LifeSciences, Inc. (GLSI) climbed 13.6% to $28.25 after HC Wainwright analyst Yi Chen maintained a Buy rating and raised the price target from $39 to $50. Analyst upgrades still move stocks, apparently.

SELLAS Life Sciences Group, Inc. (SLS) rose 12% to $3.7537 after sharing a new update on its Phase 3 REGAL trial, which is testing GPS as a potential maintenance therapy for patients with acute myeloid leukemia who have achieved a second complete remission.

Other notable gainers included Fermi Inc. (FRMI), up 8.5% to $8.16, and Redwire Corporation (RDW), which gained 8.3% to $7.61.

Intuitive Machines, Inc. (LUNR) shares rose 7% to $16.75, while ACM Research, Inc. (ACMR) gained 6.2% to $42.44. ACM Research announced it will release its full-year 2025 preliminary revenue range and initial 2026 revenue outlook on January 22, 2026.

Rounding out the list, AST SpaceMobile, Inc. (ASTS) gained 6.1% to $75.87, and Compass Diversified (CODI) rose 5.4% to $4.9350.

Back to Stock Market News

These Stocks Climbed While the Market Took a Breather Tuesday

MarketDash Editorial Team
4 hours ago
While the Dow Jones slipped slightly on Tuesday, a handful of stocks defied the downward trend. CapsoVision led the charge with an 8.4% gain after submitting an FDA application for its AI-assisted capsule endoscopy module, while AXT and Ultragenyx both surged over 13% on company-specific catalysts.

The broader market wasn't exactly throwing a party on Tuesday, with the Dow Jones index dipping more than 0.1%. But while the major indices were taking a collective nap, some individual stocks were wide awake and climbing.

CapsoVision, Inc. (CV) led the day's winners with a sharp rally during Tuesday's trading session. The medical device company submitted its 510(k) application to the FDA for its proprietary AI-assisted module for CapsoCam Plus, a development that investors clearly liked. Shares jumped 8.4% to $12.55.

The Day's Other Big Movers

Several other stocks posted impressive gains despite the lackluster market backdrop:

AXT, Inc. (AXTI) soared 13.5% to $16.56 after announcing it priced an $87 million public offering of 7,098,492 shares at $12.25 per share. That pricing came in well below where the stock was trading, which might seem counterintuitive to the rally, but the market apparently focused on the capital raise itself.

Ultragenyx Pharmaceutical Inc. (RARE) bounced back with a 13.6% gain to $22.40. This looks like a classic dead cat bounce after the stock plunged 42% on Monday when the company and partner Mereo BioPharma Group plc (MREO) disclosed disappointing late-stage data for their rare bone disease program. Sometimes stocks fall so hard they just have to recover a bit.

Greenwich LifeSciences, Inc. (GLSI) climbed 13.6% to $28.25 after HC Wainwright analyst Yi Chen maintained a Buy rating and raised the price target from $39 to $50. Analyst upgrades still move stocks, apparently.

SELLAS Life Sciences Group, Inc. (SLS) rose 12% to $3.7537 after sharing a new update on its Phase 3 REGAL trial, which is testing GPS as a potential maintenance therapy for patients with acute myeloid leukemia who have achieved a second complete remission.

Other notable gainers included Fermi Inc. (FRMI), up 8.5% to $8.16, and Redwire Corporation (RDW), which gained 8.3% to $7.61.

Intuitive Machines, Inc. (LUNR) shares rose 7% to $16.75, while ACM Research, Inc. (ACMR) gained 6.2% to $42.44. ACM Research announced it will release its full-year 2025 preliminary revenue range and initial 2026 revenue outlook on January 22, 2026.

Rounding out the list, AST SpaceMobile, Inc. (ASTS) gained 6.1% to $75.87, and Compass Diversified (CODI) rose 5.4% to $4.9350.